These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 21707682)
1. Kinetics of butyrate metabolism in the normal colon and in ulcerative colitis: the effects of substrate concentration and carnitine on the β-oxidation pathway. De Preter V; Geboes KP; Bulteel V; Vandermeulen G; Suenaert P; Rutgeerts P; Verbeke K Aliment Pharmacol Ther; 2011 Sep; 34(5):526-32. PubMed ID: 21707682 [TBL] [Abstract][Full Text] [Related]
2. Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa. De Preter V; Bulteel V; Suenaert P; Geboes KP; De Hertogh G; Luypaerts A; Geboes K; Verbeke K; Rutgeerts P Inflamm Bowel Dis; 2009 Mar; 15(3):335-40. PubMed ID: 18942762 [TBL] [Abstract][Full Text] [Related]
3. Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway. De Preter V; Arijs I; Windey K; Vanhove W; Vermeire S; Schuit F; Rutgeerts P; Verbeke K Inflamm Bowel Dis; 2012 Jun; 18(6):1127-36. PubMed ID: 21987487 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of rectally administering [1-(13)C]-butyrate for breath test in patients with active and quiescent ulcerative colitis. Kato K; Ishii Y; Mizuno S; Sugitani M; Asai S; Kohno T; Takahashi K; Komuro S; Iwamoto M; Miyamoto S; Takayama T; Arakawa Y Scand J Gastroenterol; 2007 Feb; 42(2):207-14. PubMed ID: 17327940 [TBL] [Abstract][Full Text] [Related]
5. Decreased mucosal sulfide detoxification is related to an impaired butyrate oxidation in ulcerative colitis. De Preter V; Arijs I; Windey K; Vanhove W; Vermeire S; Schuit F; Rutgeerts P; Verbeke K Inflamm Bowel Dis; 2012 Dec; 18(12):2371-80. PubMed ID: 22434643 [TBL] [Abstract][Full Text] [Related]
6. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study. Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381 [TBL] [Abstract][Full Text] [Related]
7. The colonic epithelium in ulcerative colitis: an energy-deficiency disease? Roediger WE Lancet; 1980 Oct; 2(8197):712-5. PubMed ID: 6106826 [TBL] [Abstract][Full Text] [Related]
8. Butyrate oxidation is impaired in the colonic mucosa of sufferers of quiescent ulcerative colitis. Chapman MA; Grahn MF; Boyle MA; Hutton M; Rogers J; Williams NS Gut; 1994 Jan; 35(1):73-6. PubMed ID: 8307454 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 1 beta (IL-1 beta) release from fresh and cultured colonic mucosa in patients with ulcerative colitis (UC). Gionchetti P; Campieri M; Belluzzi A; Tampieri M; Bertinelli E; Brignola C; Ferretti M; Boni P; Iannone P; Miglioli M Agents Actions; 1992; Spec No():C50-2. PubMed ID: 1442335 [TBL] [Abstract][Full Text] [Related]
11. In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis. Den Hond E; Hiele M; Evenepoel P; Peeters M; Ghoos Y; Rutgeerts P Gastroenterology; 1998 Sep; 115(3):584-90. PubMed ID: 9721155 [TBL] [Abstract][Full Text] [Related]
12. Ileal and colonic epithelial metabolism in quiescent ulcerative colitis: increased glutamine metabolism in distal colon but no defect in butyrate metabolism. Finnie IA; Taylor BA; Rhodes JM Gut; 1993 Nov; 34(11):1552-8. PubMed ID: 8244143 [TBL] [Abstract][Full Text] [Related]
13. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. Vieira EL; Leonel AJ; Sad AP; Beltrão NR; Costa TF; Ferreira TM; Gomes-Santos AC; Faria AM; Peluzio MC; Cara DC; Alvarez-Leite JI J Nutr Biochem; 2012 May; 23(5):430-6. PubMed ID: 21658926 [TBL] [Abstract][Full Text] [Related]
14. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis. Yantiss RK; Das KM; Farraye FA; Odze RD Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596 [TBL] [Abstract][Full Text] [Related]
15. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis. Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269 [TBL] [Abstract][Full Text] [Related]
16. Polyamine metabolism in colonic mucosa from patients with ulcerative colitis. Obayashi M; Matsui-Yuasa I; Matsumoto T; Kitano A; Kobayashi K; Otani S Am J Gastroenterol; 1992 Jun; 87(6):736-40. PubMed ID: 1590311 [TBL] [Abstract][Full Text] [Related]
17. Kinetic studies on colonocyte metabolism of short chain fatty acids and glucose in ulcerative colitis. Clausen MR; Mortensen PB Gut; 1995 Nov; 37(5):684-9. PubMed ID: 8549946 [TBL] [Abstract][Full Text] [Related]